{"transactions":[{"id":732916,"issuer":{"id":4718,"kind":"organization","name":"Immatics N.V."},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T20:44:25.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These Options vest 100% on the first anniversary of the grant date, June 16, 2026."}],"balance_after":48000,"derivative":{"exercise_price":9.09,"expiration_date":"2036-06-15","underlying":"Ordinary Shares","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0000950103-26-009242","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809196/000095010326009242/ownership.xml","form_type":"4"}},{"id":2224933,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-06-21T22:15:00.000Z","date":"2022-06-16","kind":"disposition_to_issuer","acquired":false,"shares":20320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 12, 2020, Mallinckrodt plc, an Irish public limited company in examination under Part 10 of the Companies Act 2014 of Ireland (\"Mallinckrodt\"), and certain of its subsidiaries voluntarily initiated proceedings under chapter 11 of title 11 of the United States Code (the \"Bankruptcy Code\") in the U.S. Bankruptcy Court for the District of Delaware (the \"Bankruptcy Court\"). On February 3, 2022, the Bankruptcy Court issued an opinion (which was subsequently revised on February 8, 2022 to make minor corrections) stating its intention to confirm Mallinckrodt's Fourth Amended Joint Plan of Reorganization of Mallinckrodt Plc and Its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) On March 2, 2022, the Bankruptcy Court entered an order confirming the Fourth Amended Joint Plan of Reorganization (with Technical Modifications) of Mallinckrodt Plc and Its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code (as amended, supplemented or otherwise modified, the \"Plan\"), and on June 16, 2022 (the \"Effective Date\"), the Plan became effective and Mallinckrodt emerged from bankruptcy."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On the Effective Date, all of Mallinckrodt's previously outstanding ordinary shares (the \"Ordinary Shares\"), including options, warrants, rights, restricted stock units or other securities or agreements to acquire such ordinary shares, were cancelled and extinguished pursuant to the Plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-023432","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000089924322023432/doc4.xml","form_type":"4"}},{"id":3146812,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-05-15T20:20:15.000Z","date":"2020-05-13","kind":"tax_withholding","acquired":false,"shares":9117,"price":2.96,"value":26986.32,"ownership":{"direct":true},"balance_after":20320,"source":{"system":"sec-edgar","filing":"0000950138-20-000257","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013820000257/edgar.xml","form_type":"4"}},{"id":3388566,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T18:55:08.000Z","date":"2019-10-22","kind":"disposition_to_issuer","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On September 16, 2019, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with H. Lundbeck A/S (\"Lundbeck\"), Lundbeck LLC and Violet Acquisition Corp., a wholly owned subsidiary of Lundbeck (\"Purchaser\").  On October 22, 2019 (the \"Effective Time\"), Purchaser merged with and into the Issuer pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Issuer being the surviving corporation and becoming a wholly-owned subsidiary of Lundbeck."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to this option, whether or not vested, were cancelled and converted into the right to receive both (i) a cash payment equal to (A) the excess, if any of (x) $18.00 over (y) the Exercise Price per share listed in Column 2 of Table II of this Form 4, multiplied by (B) the total number of shares listed in Column 5 of Table II of this Form 4, and (ii) one non-transferable contingent value right for each share subject to this option, which represents the contractual right to receive up to an additional $2.00 per share upon achievement of a milestone."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares subject to this option shall fully vest and become exercisable on the date of the 2020 Annual Meeting of the Stockholders of the Issuer, so long as the Reporting Person provides continuous service to the Issuer through such date."}],"balance_after":0,"derivative":{"exercise_price":11.01,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-19-053911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119053911/doc4.xml","form_type":"4"}},{"id":3388565,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T18:55:08.000Z","date":"2019-10-22","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On September 16, 2019, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with H. Lundbeck A/S (\"Lundbeck\"), Lundbeck LLC and Violet Acquisition Corp., a wholly owned subsidiary of Lundbeck (\"Purchaser\").  On October 22, 2019 (the \"Effective Time\"), Purchaser merged with and into the Issuer pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Issuer being the surviving corporation and becoming a wholly-owned subsidiary of Lundbeck."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to this option, whether or not vested, were cancelled and converted into the right to receive both (i) a cash payment equal to (A) the excess, if any of (x) $18.00 over (y) the Exercise Price per share listed in Column 2 of Table II of this Form 4, multiplied by (B) the total number of shares listed in Column 5 of Table II of this Form 4, and (ii) one non-transferable contingent value right for each share subject to this option, which represents the contractual right to receive up to an additional $2.00 per share upon achievement of a milestone."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to this option shall fully vest and become exercisable on the date of the 2019 Annual Meeting of the Stockholders of the Issuer, so long as the Reporting Person provides continuous service to the Issuer through such date.  The shares subject to this option are fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":15.5,"expiration_date":"2028-05-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-053911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119053911/doc4.xml","form_type":"4"}},{"id":3388564,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T18:55:08.000Z","date":"2019-10-22","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On September 16, 2019, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with H. Lundbeck A/S (\"Lundbeck\"), Lundbeck LLC and Violet Acquisition Corp., a wholly owned subsidiary of Lundbeck (\"Purchaser\").  On October 22, 2019 (the \"Effective Time\"), Purchaser merged with and into the Issuer pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Issuer being the surviving corporation and becoming a wholly-owned subsidiary of Lundbeck."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option shall fully vest and become exercisable on the date of the 2018 Annual Meeting of the Stockholders of the Issuer, so long as the Reporting Person provides continuous service to the Issuer through such date.  The shares subject to this option are fully vested as of the date hereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to this option, whether or not vested, were cancelled and converted into the right to receive both (i) a cash payment equal to (A) the excess, if any of (x) $18.00 over (y) the Exercise Price per share listed in Column 2 of Table II of this Form 4, multiplied by (B) the total number of shares listed in Column 5 of Table II of this Form 4, and (ii) one non-transferable contingent value right for each share subject to this option, which represents the contractual right to receive up to an additional $2.00 per share upon achievement of a milestone."}],"balance_after":0,"derivative":{"exercise_price":16.9,"expiration_date":"2027-05-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-053911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119053911/doc4.xml","form_type":"4"}},{"id":3388563,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T18:55:08.000Z","date":"2019-10-22","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On September 16, 2019, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with H. Lundbeck A/S (\"Lundbeck\"), Lundbeck LLC and Violet Acquisition Corp., a wholly owned subsidiary of Lundbeck (\"Purchaser\").  On October 22, 2019 (the \"Effective Time\"), Purchaser merged with and into the Issuer pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Issuer being the surviving corporation and becoming a wholly-owned subsidiary of Lundbeck."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option, whether or not vested, were cancelled at the Effective Time without any consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall fully vest and become exercisable on the date of the 2017 Annual Meeting of the Stockholders of the Issuer, so long as the Reporting Person provides continuous service to the Issuer through such date.  The shares subject to this option are fully vested as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":29.26,"expiration_date":"2026-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-053911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119053911/doc4.xml","form_type":"4"}},{"id":3388562,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T18:55:08.000Z","date":"2019-10-22","kind":"disposition_to_issuer","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On September 16, 2019, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with H. Lundbeck A/S (\"Lundbeck\"), Lundbeck LLC and Violet Acquisition Corp., a wholly owned subsidiary of Lundbeck (\"Purchaser\").  On October 22, 2019 (the \"Effective Time\"), Purchaser merged with and into the Issuer pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Issuer being the surviving corporation and becoming a wholly-owned subsidiary of Lundbeck."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable at a rate of one-third of the shares underlying the option on the one-year anniversary of September 28, 2015, the vesting commencement date, one-third of the shares underlying the option on the two-year anniversary of the vesting commencement date and one-third of the shares underlying the option on the three-year anniversary of the vesting commencement date, for so long as the recipient of the option provides continuous service to the issuer, such that the total shares shall be fully vested on the three-year anniversary of the vesting commencement date.  The shares subject to this option are fully vested as of the date hereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option, whether or not vested, were cancelled at the Effective Time without any consideration payable therefor."}],"balance_after":0,"derivative":{"exercise_price":31.1,"expiration_date":"2025-09-27","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-053911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119053911/doc4.xml","form_type":"4"}},{"id":3510246,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-28T18:12:12.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall fully vest and become exercisable on the date of the 2020 Annual Meeting of the Stockholders of the Issuer, so long as the Reporting Person provides continuous service to the Issuer through such date."}],"balance_after":22500,"derivative":{"exercise_price":11.01,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-19-033071","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119033071/doc4.xml","form_type":"4"}},{"id":3520150,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-17T10:53:14.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":19396,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units that vest in their entirety as of the date of the Company's 2020 Annual General Meeting. The restricted stock units settle in ordinary shares upon vesting."}],"balance_after":29437,"source":{"system":"sec-edgar","filing":"0000950138-19-000308","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013819000308/edgar.xml","form_type":"4"}},{"id":3520149,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-17T10:53:14.000Z","date":"2019-05-15","kind":"tax_withholding","acquired":false,"shares":8906,"price":15.21,"value":135460.26,"ownership":{"direct":true},"balance_after":10041,"source":{"system":"sec-edgar","filing":"0000950138-19-000308","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013819000308/edgar.xml","form_type":"4"}},{"id":3916948,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-25T17:23:28.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall fully vest and become exercisable on the date of the 2019 Annual Meeting of the Stockholders of the Issuer, so long as the Reporting Person provides continuous service to the Issuer through such date."}],"balance_after":15000,"derivative":{"exercise_price":15.5,"expiration_date":"2028-05-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-033607","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919118033607/doc4.xml","form_type":"4"}},{"id":3925341,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-18T20:32:30.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":18947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units that vest in their entirety as of the date of the Company's 2019 Annual General Meeting. The restricted stock units settle in ordinary shares upon vesting."}],"balance_after":18947,"source":{"system":"sec-edgar","filing":"0000950138-18-000421","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013818000421/edgar.xml","form_type":"4"}},{"id":4302888,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-26T17:47:55.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall fully vest and become exercisable on the date of the 2018 Annual Meeting of the Stockholders of the Issuer, so long as the Reporting Person provides continuous service to the Issuer through such date."}],"balance_after":15000,"derivative":{"exercise_price":16.9,"expiration_date":"2027-05-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-035976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919117035976/doc4.xml","form_type":"4"}},{"id":436004,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-08-03T20:48:37.000Z","date":"2016-08-01","kind":"exercise","acquired":false,"shares":183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":26043,"derivative":{"exercise_price":24.905,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":183},"source":{"system":"sec-edgar","filing":"0001127602-16-059414","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216059414/form4.xml","form_type":"4"}},{"id":436003,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-08-03T20:48:37.000Z","date":"2016-08-01","kind":"exercise","acquired":false,"shares":1817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":4803,"derivative":{"exercise_price":40.56,"expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":1817},"source":{"system":"sec-edgar","filing":"0001127602-16-059414","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216059414/form4.xml","form_type":"4"}},{"id":436002,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-08-03T20:48:37.000Z","date":"2016-08-01","kind":"sale","acquired":false,"shares":2000,"price":79.81,"value":159620.0,"ownership":{"direct":true},"balance_after":62305,"source":{"system":"sec-edgar","filing":"0001127602-16-059414","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216059414/form4.xml","form_type":"4"}},{"id":436001,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-08-03T20:48:37.000Z","date":"2016-08-01","kind":"exercise","acquired":true,"shares":183,"price":24.905,"value":4557.615,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":64305,"source":{"system":"sec-edgar","filing":"0001127602-16-059414","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216059414/form4.xml","form_type":"4"}},{"id":436000,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-08-03T20:48:37.000Z","date":"2016-08-01","kind":"exercise","acquired":true,"shares":1817,"price":40.56,"value":73697.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":64122,"source":{"system":"sec-edgar","filing":"0001127602-16-059414","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216059414/form4.xml","form_type":"4"}},{"id":436071,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Restricted Stock Unit","published_at":"2016-08-02T20:43:20.000Z","date":"2016-07-31","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest 25% annually over a four year period after the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest 25% annually over a four year period after the date of grant."}],"balance_after":2500,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001127602-16-059283","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216059283/form4.xml","form_type":"4"}},{"id":436070,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-08-02T20:43:20.000Z","date":"2016-07-31","kind":"tax_withholding","acquired":false,"shares":1317,"price":79.47,"value":104661.99,"ownership":{"direct":true},"balance_after":62305,"source":{"system":"sec-edgar","filing":"0001127602-16-059283","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216059283/form4.xml","form_type":"4"}},{"id":436069,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-08-02T20:43:20.000Z","date":"2016-07-31","kind":"exercise","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":63622,"source":{"system":"sec-edgar","filing":"0001127602-16-059283","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216059283/form4.xml","form_type":"4"}},{"id":436965,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-07-06T17:26:14.000Z","date":"2016-07-01","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":26226,"derivative":{"exercise_price":24.905,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001127602-16-057490","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216057490/form4.xml","form_type":"4"}},{"id":436964,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-07-06T17:26:14.000Z","date":"2016-07-01","kind":"sale","acquired":false,"shares":2000,"price":83.1248,"value":166249.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $83.02 to $83.25.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":61122,"source":{"system":"sec-edgar","filing":"0001127602-16-057490","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216057490/form4.xml","form_type":"4"}},{"id":436963,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-07-06T17:26:14.000Z","date":"2016-07-01","kind":"exercise","acquired":true,"shares":2000,"price":24.905,"value":49810.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":63122,"source":{"system":"sec-edgar","filing":"0001127602-16-057490","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216057490/form4.xml","form_type":"4"}},{"id":437678,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-06-03T20:46:56.000Z","date":"2016-06-01","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":28226,"derivative":{"exercise_price":24.905,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001127602-16-054725","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216054725/form4.xml","form_type":"4"}},{"id":437677,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-06-03T20:46:56.000Z","date":"2016-06-01","kind":"sale","acquired":false,"shares":2000,"price":87.0201,"value":174040.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $87.0101 to $87.03.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":61122,"source":{"system":"sec-edgar","filing":"0001127602-16-054725","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216054725/form4.xml","form_type":"4"}},{"id":437676,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-06-03T20:46:56.000Z","date":"2016-06-01","kind":"exercise","acquired":true,"shares":2000,"price":24.905,"value":49810.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":63122,"source":{"system":"sec-edgar","filing":"0001127602-16-054725","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216054725/form4.xml","form_type":"4"}},{"id":437709,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-06-02T20:35:44.000Z","date":"2016-05-31","kind":"exercise","acquired":false,"shares":3865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":16906,"derivative":{"exercise_price":80.65,"expiration_date":"2024-02-01","underlying":"Common Stock","underlying_shares":3865},"source":{"system":"sec-edgar","filing":"0001127602-16-054483","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216054483/form4.xml","form_type":"4"}},{"id":437708,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-06-02T20:35:44.000Z","date":"2016-05-31","kind":"exercise","acquired":false,"shares":5795,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":80.65,"expiration_date":"2024-02-01","underlying":"Common Stock","underlying_shares":5795},"source":{"system":"sec-edgar","filing":"0001127602-16-054483","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216054483/form4.xml","form_type":"4"}},{"id":437707,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-06-02T20:35:44.000Z","date":"2016-05-31","kind":"exercise","acquired":false,"shares":4232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":30226,"derivative":{"exercise_price":24.905,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":4232},"source":{"system":"sec-edgar","filing":"0001127602-16-054483","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216054483/form4.xml","form_type":"4"}},{"id":437706,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-06-02T20:35:44.000Z","date":"2016-05-31","kind":"exercise","acquired":false,"shares":43200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":24.295,"expiration_date":"2022-01-26","underlying":"Common Stock","underlying_shares":43200},"source":{"system":"sec-edgar","filing":"0001127602-16-054483","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216054483/form4.xml","form_type":"4"}},{"id":437705,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-06-02T20:35:44.000Z","date":"2016-05-31","kind":"sale","acquired":false,"shares":57092,"price":86.8528,"value":4958600.0576,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $86.6075 to $87.1008.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":61122,"source":{"system":"sec-edgar","filing":"0001127602-16-054483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216054483/form4.xml","form_type":"4"}},{"id":437704,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-06-02T20:35:44.000Z","date":"2016-05-31","kind":"exercise","acquired":true,"shares":3865,"price":80.65,"value":311712.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":118214,"source":{"system":"sec-edgar","filing":"0001127602-16-054483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216054483/form4.xml","form_type":"4"}},{"id":437703,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-06-02T20:35:44.000Z","date":"2016-05-31","kind":"exercise","acquired":true,"shares":5795,"price":80.65,"value":467366.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":114349,"source":{"system":"sec-edgar","filing":"0001127602-16-054483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216054483/form4.xml","form_type":"4"}},{"id":437702,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-06-02T20:35:44.000Z","date":"2016-05-31","kind":"exercise","acquired":true,"shares":4232,"price":24.905,"value":105397.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":108554,"source":{"system":"sec-edgar","filing":"0001127602-16-054483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216054483/form4.xml","form_type":"4"}},{"id":437701,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-06-02T20:35:44.000Z","date":"2016-05-31","kind":"exercise","acquired":true,"shares":43200,"price":24.295,"value":1049544.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":104322,"source":{"system":"sec-edgar","filing":"0001127602-16-054483","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216054483/form4.xml","form_type":"4"}},{"id":438743,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-05-04T20:23:38.000Z","date":"2016-05-02","kind":"exercise","acquired":false,"shares":183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":34458,"derivative":{"exercise_price":24.905,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":183},"source":{"system":"sec-edgar","filing":"0001127602-16-051112","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216051112/form4.xml","form_type":"4"}},{"id":438742,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-05-04T20:23:38.000Z","date":"2016-05-02","kind":"exercise","acquired":false,"shares":1817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":6620,"derivative":{"exercise_price":40.56,"expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":1817},"source":{"system":"sec-edgar","filing":"0001127602-16-051112","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216051112/form4.xml","form_type":"4"}},{"id":438741,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-05-04T20:23:38.000Z","date":"2016-05-02","kind":"sale","acquired":false,"shares":2000,"price":88.7239,"value":177447.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $88.715 to $88.765.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":61122,"source":{"system":"sec-edgar","filing":"0001127602-16-051112","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216051112/form4.xml","form_type":"4"}},{"id":438740,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-05-04T20:23:38.000Z","date":"2016-05-02","kind":"exercise","acquired":true,"shares":183,"price":24.905,"value":4557.615,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":63122,"source":{"system":"sec-edgar","filing":"0001127602-16-051112","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216051112/form4.xml","form_type":"4"}},{"id":438739,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-05-04T20:23:38.000Z","date":"2016-05-02","kind":"exercise","acquired":true,"shares":1817,"price":40.56,"value":73697.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":62939,"source":{"system":"sec-edgar","filing":"0001127602-16-051112","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216051112/form4.xml","form_type":"4"}},{"id":439630,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-04-05T22:36:13.000Z","date":"2016-04-01","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":34641,"derivative":{"exercise_price":24.905,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001127602-16-048891","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216048891/form4.xml","form_type":"4"}},{"id":439629,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-04-05T22:36:13.000Z","date":"2016-04-01","kind":"sale","acquired":false,"shares":2000,"price":91.34,"value":182680.0,"ownership":{"direct":true},"balance_after":61122,"source":{"system":"sec-edgar","filing":"0001127602-16-048891","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216048891/form4.xml","form_type":"4"}},{"id":439628,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-04-05T22:36:13.000Z","date":"2016-04-01","kind":"exercise","acquired":true,"shares":2000,"price":24.905,"value":49810.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":63122,"source":{"system":"sec-edgar","filing":"0001127602-16-048891","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216048891/form4.xml","form_type":"4"}},{"id":440930,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2016-03-03T20:10:57.000Z","date":"2016-03-01","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":36641,"derivative":{"exercise_price":24.905,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001127602-16-044760","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216044760/form4.xml","form_type":"4"}},{"id":440929,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-03-03T20:10:57.000Z","date":"2016-03-01","kind":"sale","acquired":false,"shares":2000,"price":87.9,"value":175800.0,"ownership":{"direct":true},"balance_after":61122,"source":{"system":"sec-edgar","filing":"0001127602-16-044760","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216044760/form4.xml","form_type":"4"}},{"id":440928,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-03-03T20:10:57.000Z","date":"2016-03-01","kind":"exercise","acquired":true,"shares":2000,"price":24.905,"value":49810.0,"ownership":{"direct":true},"balance_after":63122,"source":{"system":"sec-edgar","filing":"0001127602-16-044760","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216044760/form4.xml","form_type":"4"}},{"id":441886,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-02-19T00:53:45.000Z","date":"2016-02-16","kind":"tax_withholding","acquired":false,"shares":7395,"price":91.15,"value":674054.25,"ownership":{"direct":true},"balance_after":61122,"source":{"system":"sec-edgar","filing":"0001127602-16-042271","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216042271/form4.xml","form_type":"4"}},{"id":441885,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-02-19T00:53:45.000Z","date":"2016-02-16","kind":"grant","acquired":true,"shares":9554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2013. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors."}],"balance_after":68517,"source":{"system":"sec-edgar","filing":"0001127602-16-042271","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216042271/form4.xml","form_type":"4"}},{"id":441884,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-02-19T00:53:45.000Z","date":"2016-02-16","kind":"grant","acquired":true,"shares":9932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock subject to specific tranches of performance share awards made to the Reporting Person on February 1, 2014, and February 1, 2015. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until such individual satisfies the applicable service-vesting requirements by continuing in the Issuer's employ through December 31, 2016, and committee certifications respectively."}],"balance_after":58963,"source":{"system":"sec-edgar","filing":"0001127602-16-042271","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216042271/form4.xml","form_type":"4"}},{"id":441883,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"officer":true,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-02-19T00:53:45.000Z","date":"2016-02-15","kind":"grant","acquired":true,"shares":248,"price":76.024,"value":18853.952,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.."}],"balance_after":49031,"source":{"system":"sec-edgar","filing":"0001127602-16-042271","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760216042271/form4.xml","form_type":"4"}},{"id":442936,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-02-03T22:42:39.000Z","date":"2016-02-01","kind":"grant","acquired":true,"shares":42880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":42880,"derivative":{"exercise_price":84.05,"expiration_date":"2026-02-01","underlying":"Common Stock","underlying_shares":42880},"source":{"system":"sec-edgar","filing":"0001179110-16-018452","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911016018452/edgar.xml","form_type":"4"}},{"id":442935,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-02-03T22:42:39.000Z","date":"2016-02-01","kind":"exercise","acquired":false,"shares":1818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":8437,"derivative":{"exercise_price":40.56,"expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":1818},"source":{"system":"sec-edgar","filing":"0001179110-16-018452","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911016018452/edgar.xml","form_type":"4"}},{"id":442934,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-02-03T22:42:39.000Z","date":"2016-02-01","kind":"exercise","acquired":false,"shares":182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":38641,"derivative":{"exercise_price":24.905,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":182},"source":{"system":"sec-edgar","filing":"0001179110-16-018452","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911016018452/edgar.xml","form_type":"4"}},{"id":442933,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-02-03T22:42:39.000Z","date":"2016-02-01","kind":"sale","acquired":false,"shares":2000,"price":82.32,"value":164640.0,"ownership":{"direct":true},"balance_after":48783,"source":{"system":"sec-edgar","filing":"0001179110-16-018452","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911016018452/edgar.xml","form_type":"4"}},{"id":442932,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-02-03T22:42:39.000Z","date":"2016-02-01","kind":"exercise","acquired":true,"shares":1818,"price":40.56,"value":73738.08,"ownership":{"direct":true},"balance_after":50783,"source":{"system":"sec-edgar","filing":"0001179110-16-018452","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911016018452/edgar.xml","form_type":"4"}},{"id":442931,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-02-03T22:42:39.000Z","date":"2016-02-01","kind":"exercise","acquired":true,"shares":182,"price":24.905,"value":4532.71,"ownership":{"direct":true},"balance_after":48965,"source":{"system":"sec-edgar","filing":"0001179110-16-018452","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911016018452/edgar.xml","form_type":"4"}},{"id":443726,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-01-06T22:08:21.000Z","date":"2016-01-04","kind":"exercise","acquired":false,"shares":823,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":26.99,"expiration_date":"2018-07-30","underlying":"Common Stock","underlying_shares":823},"source":{"system":"sec-edgar","filing":"0001179110-16-017392","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911016017392/edgar.xml","form_type":"4"}},{"id":443725,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-01-06T22:08:21.000Z","date":"2016-01-04","kind":"exercise","acquired":false,"shares":1177,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":38823,"derivative":{"exercise_price":24.905,"expiration_date":"2019-07-29","underlying":"Common Stock","underlying_shares":1177},"source":{"system":"sec-edgar","filing":"0001179110-16-017392","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911016017392/edgar.xml","form_type":"4"}},{"id":443724,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-01-06T22:08:21.000Z","date":"2016-01-04","kind":"sale","acquired":false,"shares":2000,"price":99.2,"value":198400.0,"ownership":{"direct":true},"balance_after":48783,"source":{"system":"sec-edgar","filing":"0001179110-16-017392","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911016017392/edgar.xml","form_type":"4"}},{"id":443723,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-01-06T22:08:21.000Z","date":"2016-01-04","kind":"exercise","acquired":true,"shares":1177,"price":24.905,"value":29313.185,"ownership":{"direct":true},"balance_after":50783,"source":{"system":"sec-edgar","filing":"0001179110-16-017392","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911016017392/edgar.xml","form_type":"4"}},{"id":443722,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2016-01-06T22:08:21.000Z","date":"2016-01-04","kind":"exercise","acquired":true,"shares":823,"price":26.99,"value":22212.77,"ownership":{"direct":true},"balance_after":49606,"source":{"system":"sec-edgar","filing":"0001179110-16-017392","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911016017392/edgar.xml","form_type":"4"}},{"id":444531,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-12-03T18:56:49.000Z","date":"2015-12-01","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":823,"derivative":{"exercise_price":26.99,"expiration_date":"2018-07-30","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001179110-15-015665","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015015665/edgar.xml","form_type":"4"}},{"id":444530,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-12-03T18:56:49.000Z","date":"2015-12-01","kind":"sale","acquired":false,"shares":2000,"price":106.38,"value":212760.0,"ownership":{"direct":true},"balance_after":48783,"source":{"system":"sec-edgar","filing":"0001179110-15-015665","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015015665/edgar.xml","form_type":"4"}},{"id":444529,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-12-03T18:56:49.000Z","date":"2015-12-01","kind":"exercise","acquired":true,"shares":2000,"price":26.99,"value":53980.0,"ownership":{"direct":true},"balance_after":50783,"source":{"system":"sec-edgar","filing":"0001179110-15-015665","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015015665/edgar.xml","form_type":"4"}},{"id":445402,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-11-04T21:27:20.000Z","date":"2015-11-02","kind":"exercise","acquired":false,"shares":1816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":10255,"derivative":{"exercise_price":40.56,"expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":1816},"source":{"system":"sec-edgar","filing":"0001179110-15-014474","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015014474/edgar.xml","form_type":"4"}},{"id":445401,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-11-04T21:27:20.000Z","date":"2015-11-02","kind":"exercise","acquired":false,"shares":184,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":2823,"derivative":{"exercise_price":26.99,"expiration_date":"2018-07-30","underlying":"Common Stock","underlying_shares":184},"source":{"system":"sec-edgar","filing":"0001179110-15-014474","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015014474/edgar.xml","form_type":"4"}},{"id":445400,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-11-04T21:27:20.000Z","date":"2015-11-02","kind":"sale","acquired":false,"shares":2000,"price":108.356,"value":216712.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $108.33 to $108.42.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":48783,"source":{"system":"sec-edgar","filing":"0001179110-15-014474","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015014474/edgar.xml","form_type":"4"}},{"id":445399,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-11-04T21:27:20.000Z","date":"2015-11-02","kind":"exercise","acquired":false,"shares":1816,"price":40.56,"value":73656.96,"ownership":{"direct":true},"balance_after":50783,"source":{"system":"sec-edgar","filing":"0001179110-15-014474","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015014474/edgar.xml","form_type":"4"}},{"id":445398,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-11-04T21:27:20.000Z","date":"2015-11-02","kind":"exercise","acquired":false,"shares":184,"price":26.99,"value":4966.16,"ownership":{"direct":true},"balance_after":48967,"source":{"system":"sec-edgar","filing":"0001179110-15-014474","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015014474/edgar.xml","form_type":"4"}},{"id":445615,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-10-28T18:51:36.000Z","date":"2015-10-26","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":3007,"derivative":{"exercise_price":26.99,"expiration_date":"2018-07-30","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001179110-15-014252","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015014252/edgar.xml","form_type":"4"}},{"id":445614,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-10-28T18:51:36.000Z","date":"2015-10-26","kind":"sale","acquired":false,"shares":1500,"price":110.0613,"value":165091.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $110.05 to $110.10.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":48783,"source":{"system":"sec-edgar","filing":"0001179110-15-014252","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015014252/edgar.xml","form_type":"4"}},{"id":445613,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-10-28T18:51:36.000Z","date":"2015-10-26","kind":"exercise","acquired":false,"shares":1500,"price":26.99,"value":40485.0,"ownership":{"direct":true},"balance_after":50283,"source":{"system":"sec-edgar","filing":"0001179110-15-014252","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015014252/edgar.xml","form_type":"4"}},{"id":446010,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-10-05T20:26:34.000Z","date":"2015-10-01","kind":"exercise","acquired":false,"shares":1820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":12071,"derivative":{"exercise_price":40.56,"expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":1820},"source":{"system":"sec-edgar","filing":"0001179110-15-013794","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015013794/edgar.xml","form_type":"4"}},{"id":446009,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-10-05T20:26:34.000Z","date":"2015-10-01","kind":"exercise","acquired":false,"shares":180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":4507,"derivative":{"exercise_price":26.99,"expiration_date":"2018-07-30","underlying":"Common Stock","underlying_shares":180},"source":{"system":"sec-edgar","filing":"0001179110-15-013794","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015013794/edgar.xml","form_type":"4"}},{"id":446008,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-10-05T20:26:34.000Z","date":"2015-10-01","kind":"sale","acquired":false,"shares":2000,"price":98.59,"value":197180.0,"ownership":{"direct":true},"balance_after":48783,"source":{"system":"sec-edgar","filing":"0001179110-15-013794","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015013794/edgar.xml","form_type":"4"}},{"id":446007,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-10-05T20:26:34.000Z","date":"2015-10-01","kind":"exercise","acquired":false,"shares":1820,"price":40.56,"value":73819.2,"ownership":{"direct":true},"balance_after":50783,"source":{"system":"sec-edgar","filing":"0001179110-15-013794","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015013794/edgar.xml","form_type":"4"}},{"id":446006,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-10-05T20:26:34.000Z","date":"2015-10-01","kind":"exercise","acquired":false,"shares":180,"price":26.99,"value":4858.2,"ownership":{"direct":true},"balance_after":48963,"source":{"system":"sec-edgar","filing":"0001179110-15-013794","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015013794/edgar.xml","form_type":"4"}},{"id":448106,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-08-04T21:08:40.000Z","date":"2015-08-03","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":4687,"derivative":{"exercise_price":26.99,"expiration_date":"2018-07-30","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001179110-15-011695","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015011695/edgar.xml","form_type":"4"}},{"id":448105,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-08-04T21:08:40.000Z","date":"2015-08-03","kind":"sale","acquired":false,"shares":2000,"price":120,"value":240000.0,"ownership":{"direct":true},"balance_after":48783,"source":{"system":"sec-edgar","filing":"0001179110-15-011695","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015011695/edgar.xml","form_type":"4"}},{"id":448104,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-08-04T21:08:40.000Z","date":"2015-08-03","kind":"sale","acquired":false,"shares":3000,"price":118.64,"value":355920.0,"ownership":{"direct":true},"balance_after":50783,"source":{"system":"sec-edgar","filing":"0001179110-15-011695","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015011695/edgar.xml","form_type":"4"}},{"id":448103,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-08-04T21:08:40.000Z","date":"2015-08-03","kind":"exercise","acquired":true,"shares":5000,"price":26.99,"value":134950.0,"ownership":{"direct":true},"balance_after":53783,"source":{"system":"sec-edgar","filing":"0001179110-15-011695","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015011695/edgar.xml","form_type":"4"}},{"id":448129,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Restricted Stock Unit","published_at":"2015-08-04T21:00:50.000Z","date":"2015-07-31","kind":"exercise","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest 25% annually over a four year period after the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest 25% annually over a four year period after the date of grant."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001179110-15-011691","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015011691/edgar.xml","form_type":"4"}},{"id":448128,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-08-04T21:00:50.000Z","date":"2015-07-31","kind":"tax_withholding","acquired":false,"shares":1349,"price":117.86,"value":158993.14,"ownership":{"direct":true},"balance_after":48783,"source":{"system":"sec-edgar","filing":"0001179110-15-011691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015011691/edgar.xml","form_type":"4"}},{"id":448127,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-08-04T21:00:50.000Z","date":"2015-07-31","kind":"exercise","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50132,"source":{"system":"sec-edgar","filing":"0001179110-15-011691","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015011691/edgar.xml","form_type":"4"}},{"id":449115,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-07-06T20:00:50.000Z","date":"2015-07-01","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":9687,"derivative":{"exercise_price":26.99,"expiration_date":"2018-07-30","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001179110-15-010896","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015010896/edgar.xml","form_type":"4"}},{"id":449114,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-07-06T20:00:50.000Z","date":"2015-07-01","kind":"sale","acquired":false,"shares":3000,"price":118.243,"value":354729.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $118.18 to $118.25.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":47632,"source":{"system":"sec-edgar","filing":"0001179110-15-010896","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015010896/edgar.xml","form_type":"4"}},{"id":449113,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-07-06T20:00:50.000Z","date":"2015-07-01","kind":"exercise","acquired":true,"shares":3000,"price":26.99,"value":80970.0,"ownership":{"direct":true},"balance_after":50632,"source":{"system":"sec-edgar","filing":"0001179110-15-010896","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015010896/edgar.xml","form_type":"4"}},{"id":449514,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-06-22T20:17:37.000Z","date":"2015-06-18","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":12687,"derivative":{"exercise_price":26.99,"expiration_date":"2018-07-30","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-15-010128","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015010128/edgar.xml","form_type":"4"}},{"id":449513,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-06-22T20:17:37.000Z","date":"2015-06-18","kind":"sale","acquired":false,"shares":10000,"price":120.0025,"value":1200025.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $120.00 to $120.04.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":47632,"source":{"system":"sec-edgar","filing":"0001179110-15-010128","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015010128/edgar.xml","form_type":"4"}},{"id":449512,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-06-22T20:17:37.000Z","date":"2015-06-18","kind":"exercise","acquired":true,"shares":10000,"price":26.99,"value":269900.0,"ownership":{"direct":true},"balance_after":57632,"source":{"system":"sec-edgar","filing":"0001179110-15-010128","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015010128/edgar.xml","form_type":"4"}},{"id":450061,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-06-03T22:07:18.000Z","date":"2015-06-01","kind":"exercise","acquired":false,"shares":1706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":13891,"derivative":{"exercise_price":40.56,"expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":1706},"source":{"system":"sec-edgar","filing":"0001179110-15-009083","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015009083/edgar.xml","form_type":"4"}},{"id":450060,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-06-03T22:07:18.000Z","date":"2015-06-01","kind":"exercise","acquired":false,"shares":1294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":22687,"derivative":{"exercise_price":26.99,"expiration_date":"2018-07-30","underlying":"Common Stock","underlying_shares":1294},"source":{"system":"sec-edgar","filing":"0001179110-15-009083","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015009083/edgar.xml","form_type":"4"}},{"id":450059,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-06-03T22:07:18.000Z","date":"2015-06-01","kind":"sale","acquired":false,"shares":3000,"price":113.0925,"value":339277.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $113.01 to $113.2050.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":47632,"source":{"system":"sec-edgar","filing":"0001179110-15-009083","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015009083/edgar.xml","form_type":"4"}},{"id":450058,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-06-03T22:07:18.000Z","date":"2015-06-01","kind":"exercise","acquired":true,"shares":1294,"price":26.99,"value":34925.06,"ownership":{"direct":true},"balance_after":50632,"source":{"system":"sec-edgar","filing":"0001179110-15-009083","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015009083/edgar.xml","form_type":"4"}},{"id":450057,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-06-03T22:07:18.000Z","date":"2015-06-01","kind":"exercise","acquired":true,"shares":1706,"price":40.56,"value":69195.36,"ownership":{"direct":true},"balance_after":49338,"source":{"system":"sec-edgar","filing":"0001179110-15-009083","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015009083/edgar.xml","form_type":"4"}},{"id":450730,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-05-19T23:24:47.000Z","date":"2015-05-15","kind":"exercise","acquired":false,"shares":4074,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":26566,"derivative":{"exercise_price":80.65,"expiration_date":"2024-02-01","underlying":"Common Stock","underlying_shares":4074},"source":{"system":"sec-edgar","filing":"0001179110-15-008135","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015008135/edgar.xml","form_type":"4"}},{"id":450729,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2015-05-19T23:24:47.000Z","date":"2015-05-15","kind":"exercise","acquired":false,"shares":1926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":15597,"derivative":{"exercise_price":40.56,"expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":1926},"source":{"system":"sec-edgar","filing":"0001179110-15-008135","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015008135/edgar.xml","form_type":"4"}},{"id":450728,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16290,"kind":"person","name":"Carter Paul Rutherford","position":1,"cik":"0001600041","reported_name":"Carter Paul Rutherford","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP  Commercial Ops"}}],"security":"Common Stock","published_at":"2015-05-19T23:24:47.000Z","date":"2015-05-15","kind":"sale","acquired":false,"shares":6000,"price":110.0034,"value":660020.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $110.00 to $110.075.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":47632,"source":{"system":"sec-edgar","filing":"0001179110-15-008135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000117911015008135/edgar.xml","form_type":"4"}}],"next_cursor":"2015-05-19T23:24:47.000000Z,450728"}